Literature DB >> 21235315

Cortical ependymoma: an unusual epileptogenic lesion.

Jamie J Van Gompel1, Kelly K Koeller, Fredric B Meyer, W Richard Marsh, Peter C Burger, Federico Roncaroli, Gregory A Worrell, Caterina Giannini.   

Abstract

OBJECT: Supratentorial cortical ependymomas (CE) are rare, with 7 cases reported. The lesions, typically occurring in the superficial cortex in young adults and associated with a history of seizures, are not fully characterized. Furthermore, their relationship with the recently described angiocentric glioma (AG) is still being debated. This study was undertaken to summarize the authors' experience with CEs.
METHODS: Between 1997 and 2009, 202 cases of ependymoma were surgically treated at the Mayo Clinic, 49 of which were supratentorial. Among these, 9 CE cases were retrospectively identified. Clinical, imaging, and pathological features of each case were reviewed.
RESULTS: Tumors arose from the frontal (5 cases), parietal (3), and occipital (1) lobes. No tumor occurred in the temporal lobe, despite its reported association with seizures. The mean age at presentation was 27 ± 19 years (± SD) and age at resection was 36 ± 16 years. The mean size of the lesion was 16 ± 14 cm(3). Seizures were the presenting symptom in 78%. Cross-sectional imaging in 8 cases was characterized by a heterogeneous mass with multiple cystlike areas and enhancement of the soft-tissue component. Gross-total resection was achieved in 8 of 9 tumors. Pathologically, 6 were low-grade (WHO Grade II) and 3 were anaplastic (WHO Grade III) ependymomas. All tumors exhibited the focal presence of perivascular pseudorosettes, but only 1 (11%) exhibited the focal presence of a true rosette. A bipolar spindle cell component resembling AG was present in 3 (33%) and "Schwannian-like" nodules in 2 (22%). Subpial aggregation and peripheral infiltration were present in 4 cases (44%). With a mean postsurgery follow-up of 62 ± 38 months, only 2 lesions recurred locally after imaging-confirmed gross-total resection, both being Grade III. In 5 (71%) of 7 patients presenting with seizures an Engel Class I outcome was achieved.
CONCLUSIONS: Cortical ependymomas represent a rare type of ependymoma occurring superficially in the cortex. Morphologically, these tumors are protean, varying from classic to epithelioid, clear cell, and tanycytic. Some also exhibited features typical of AG. Most tumors were low grade and cured with resection. Anaplastic tumors occur and may recur locally despite provision of radiation therapy. Cortical ependymomas frequently, but not always, present with seizures, but despite their high association with epilepsy, none occurred in the temporal lobe in any of the authors' 9 patients. Overall, CEs appear to have a relatively favorable prognosis compared with other supratentorial ependymomas.

Entities:  

Mesh:

Year:  2011        PMID: 21235315      PMCID: PMC3271434          DOI: 10.3171/2010.12.JNS10846

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  32 in total

1.  Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma.

Authors:  Min Wang; Tarik Tihan; Amyn M Rojiani; Surender R Bodhireddy; Richard A Prayson; John J Iacuone; Ajit J Alles; David J Donahue; Richard B Hessler; Jung H Kim; Mark Haas; Marc K Rosenblum; Peter C Burger
Journal:  J Neuropathol Exp Neurol       Date:  2005-10       Impact factor: 3.685

2.  Intracranial electroencephalography with subdural grid electrodes: techniques, complications, and outcomes.

Authors:  Jamie J Van Gompel; Gregory A Worrell; Michael L Bell; Todd A Patrick; Gregory D Cascino; Corey Raffel; W Richard Marsh; Fredric B Meyer
Journal:  Neurosurgery       Date:  2008-09       Impact factor: 4.654

Review 3.  Central nervous system tumors with ependymal features: a broadened spectrum of primarily ependymal differentiation?

Authors:  Norman L Lehman
Journal:  J Neuropathol Exp Neurol       Date:  2008-03       Impact factor: 3.685

4.  Cortical ependymoma or monomorphous angiocentric glioma?

Authors:  Dennis J Lum; William Halliday; Michael Watson; Andrew Smith; Andrew Law
Journal:  Neuropathology       Date:  2007-11-13       Impact factor: 1.906

5.  Supratentorial ectopic cortical ependymoma occurring with intratumoral hemorrhage.

Authors:  Takahito Miyazawa; Takanori Hirose; Kuniaki Nakanishi; Yoichi Uozumi; Nobusuke Tsuzuki; Katsuji Shima
Journal:  Brain Tumor Pathol       Date:  2007-05-25       Impact factor: 3.298

6.  Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma.

Authors:  Daniel J Brat; Bernd W Scheithauer; Gregory N Fuller; Tarik Tihan
Journal:  Brain Pathol       Date:  2007-07       Impact factor: 6.508

7.  Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients.

Authors:  Philippe Metellus; Dominique Figarella-Branger; Jacques Guyotat; Marylin Barrie; Roch Giorgi; Anne Jouvet; Olivier Chinot
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

8.  Angiocentric glioma: presentation of two cases with dissimilar histology.

Authors:  D Arsene; C Ardeleanu; I Ogrezeanu; L Danaila
Journal:  Clin Neuropathol       Date:  2008 Nov-Dec       Impact factor: 1.368

9.  Patterns of brain infiltration and secondary structure formation in supratentorial ependymal tumors.

Authors:  Norman L Lehman
Journal:  J Neuropathol Exp Neurol       Date:  2008-09       Impact factor: 3.685

10.  Both location and age predict survival in ependymoma: a SEER study.

Authors:  Courtney S McGuire; Kristin L Sainani; Paul Graham Fisher
Journal:  Pediatr Blood Cancer       Date:  2009-01       Impact factor: 3.167

View more
  12 in total

Review 1.  Supratentorial pediatric cortical ependymomas: a comprehensive retrospective study.

Authors:  Qiguang Wang; Jian Cheng; Si Zhang; Qiang Li; Xuhui Hui; Yan Ju
Journal:  Neurosurg Rev       Date:  2020-06-30       Impact factor: 3.042

2.  Supratentorial extraventricular anaplastic ependymoma presenting with repeated intratumoral hemorrhage.

Authors:  Min-Hee Han; Ki-Su Park; Seong-Hyun Park; Jeong-Hyun Hwang
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

3.  Rapidly Enlarging Pediatric Cortical Ependymoma.

Authors:  Kouji Yamasaki; Kiyotaka Yokogami; Shinji Yamashita; Hideo Takeshima
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

4.  Pure cortical ependymoma: A rare entity.

Authors:  Sanjay Bijwe; Sameer Ansari; Vinod Jadhav; Deepak Palande
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun

5.  Cortical anaplastic ependymoma with significant desmoplasia: a case report and literature review.

Authors:  Alaa Eldin Elsharkawy; Raid Abuamona; Markus Bergmann; Shadi Salem; Evariste Gafumbegete; Ernst Röttger
Journal:  Case Rep Oncol Med       Date:  2013-12-16

6.  Supratentorial cortical ependymoma: An unusual presentation of a rare tumor.

Authors:  Mohammad Reza Mohaghegh; Ahmad Chitsaz; Ali Asghar Okhovat; Elnaz Babaei Pour
Journal:  Adv Biomed Res       Date:  2015-03-25

7.  Anaplastic supratentorial cortical ependymoma presenting as a butterfly lesion.

Authors:  David W K Ng; Nicolas K K King; Aaron S C Foo; Yih-Yian Sitoh; Hwei Yee Lee; Wai Hoe Ng
Journal:  Surg Neurol Int       Date:  2012-09-13

8.  Supratentorial Pure Cortical Ependymoma: An Unusual Lesion Causing Focal Motor Aware Seizure.

Authors:  Manish Beniwal; Ajit Mishra; K V L Narasinga Rao; Vikas Vazhayil; Bevinahalli N Nandeesh; Sampath Somanna
Journal:  J Neurosci Rural Pract       Date:  2018 Apr-Jun

9.  World Health Organization Grade III Supratentorial Extraventricular Ependymomas in Adults: Case Series and Review of Treatment Modalities.

Authors:  Fotios Kalfas; Claudia Scudieri
Journal:  Asian J Neurosurg       Date:  2019-11-25

Review 10.  Case Report: Sellar Ependymomas: A Clinic-Pathological Study and Literature Review.

Authors:  Liyan Zhao; Yining Jiang; Yubo Wang; Yang Bai; Liping Liu; Yunqian Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.